ORGO 8-K 2026-08-06

Organogenesis Holdings Inc. (ORGO) 8-K dated 2026-08-06 — accession 0001193125-26-338321. This URL is the filing, not the ORGO hub.

Organogenesis Holdings Inc. (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Organogenesis Holdings Inc. filed a 8-K on 2026-08-06. Accession 0001193125-26-338321.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.

Not investment advice. The ORGO SEC hub lists recent forms. The stock page is the research view.